Are you fully embracing the predictive power of Select mdx?

Did you know we have patient resources?

Contact your local representative to order patient resources for your office.

*required

Use Cases for Select mdx:

Considering a prostate biopsy

Stratify patients that may avoid biopsy with a 99% NPV for GS≥8 and 95% NPV for GS≥7.1

Patient selection for MRI

Pre-select men for MRI that are at greater risk for GS≥7 prostate cancer. Since Medicare patients have $0 patient responsibility for Select mdx, utilizing Select mdx pre-MRI may reduce patient cost.

Determining follow-up with PI-RADS 1-3 patients

Identify patients with greater risk for GS≥7 prostate cancer despite a negative or indeterminate MRI result.

Identifying risk for patients with a negative biopsy

Stratify patients with a prior negative biopsy and increasing PSA or other risk factors to determine risk for GS≥7. While Confirm mdx is recommended for these patients, Select mdx may be used when fewer than 8 cores are available for testing.

Patients ideal for Select mdx

Patient First Promise and Satisfaction Guarantee

We believe no patient should be denied access to powerful diagnostic insights due to financial constraints. That’s why we are committed to making our tests accessible and affordable through our Patient First Promise.

Every patient, regardless of insurance status, is eligible to apply for our financial assistance program. And with our Satisfaction Guarantee, you can recommend mdxhealth tests with full confidence. If you are unsatisfied with how we handle any patient billing matter, we will refund the entire cost – no questions asked.

References

1Haese A, et al. Multicenter optimization and validation of a 2-gene mRNA urine test for detection of clinically significant prostate cancer prior to initial prostate biopsy. Journal of Urology 2019.